Founded in 2019 by the venture capital firm Forbion and John Kastelein, NewAmsterdam Pharma is a privately held, clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies are not tolerated or have been unsuccessful.

Biotechnology

New Amsterdam Pharma

New Amsterdam Pharma's headquarters in Naarden, Netherlands

Michael Davidson

BJ Jones

Matthew Philippe

Sheng Cui

David Topper

Annie Neild

Douglas Kling

John Kastelein

Wouter Joustra

Nicholas Downing

Sander Van Slootweg

Lou Lange

James N. Topper

Juliette Audet

John Smither

Stephen Nicholls

Ann Marie Navar

Christie Ballantyne

Kosh Ray

Brian Ference

Janneke van der Kamp

Description

People

Jobs